Cellebrain

South Korea
Jeonju, Jeollabuk-do, South Korea

Company profile

Cellebrain company profile

Cellebrain is a biotechnology company specializing in the development of stem cell-based gene therapy aimed at addressing neurological disorders. The company focuses on advancing therapeutic drugs by utilizing a pipeline of stem cell-based gene therapy candidates. These candidates employ mesenchymal stem cells as cell mediators to deliver therapeutic genes, providing therapy options for patients dealing with chronic stroke.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2018-01-01, Year

Headquarters

Country code
KR
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$4,170
Last funding
Series A / $4,170 / 2022-02-16
Last equity funding
Series A / $4,170
Investors
1
Articles
1

Founders and investors

Investors

Kolon Investment